Global Vaccines Innovation and Immunology Conference

Memo

Scientific breakthroughs in immunology are opening new possibilities for preventing disease and improving healthcare outcomes worldwide. The Global Vaccines Innovation and Immunology Conference (GVX Immunology 2026), scheduled for September 21–23, 2026, in London, United Kingdom, invites the international scientific community to participate either in person or through its hybrid and virtual conference experience. This global Vaccine Conference 2026 welcomes immunologists, vaccine scientists, clinicians, microbiologists, biomedical researchers, pharmaceutical professionals, biotechnology innovators, healthcare practitioners, policymakers, and postgraduate students. The Immunology Congress highlights emerging developments in vaccine discovery, immune system regulation, cellular and molecular immunology, therapeutic vaccines, clinical immunology, vaccine safety, immune biomarkers, infectious disease management, and innovative technologies supporting future medical advancements. An international gathering of experts creates opportunities to exchange scientific perspectives, establish collaborative research initiatives, strengthen institutional partnerships, and encourage interdisciplinary cooperation. Delegates representing universities, hospitals, research centres, biotechnology companies, pharmaceutical industries, and public health organizations can build lasting professional relationships while sharing valuable scientific experiences. Participants connecting through the online platform will enjoy live keynote addresses, scientific sessions, interactive discussions, and educational activities designed to encourage active engagement from every region. Immunization Conferences provides an outstanding opportunity to discover pioneering research, broaden professional networks, and support innovations that continue transforming vaccines, immunology, and global public health for future generations.